Pharmaceutical Quality Systems
GMP and cGMP
Good Manufacturing Practice (GMP) provides the regulatory and quality-system framework for consistently manufacturing and controlling medicinal products according to their intended use and approved requirements.
In the United States, the abbreviation cGMP means current Good Manufacturing Practice. The word “current” emphasizes that manufacturers are expected to use suitable, maintained and scientifically sound systems rather than relying only on practices that may have been acceptable in the past.
Core principles
- Quality must be designed into facilities, equipment, processes and controls.
- Responsibilities, procedures and decisions should be defined and documented.
- Personnel should be appropriately qualified and trained.
- Facilities and equipment should be suitable, qualified, maintained and controlled.
- Manufacturing and testing should follow approved procedures and specifications.
- Deviations, failures and complaints should be investigated, with effective corrective and preventive actions where appropriate.
- Process performance and product quality should be monitored throughout the lifecycle.
Specific expectations vary by jurisdiction, product and activity. For sterile products, EU GMP Annex 1 and FDA aseptic-processing guidance provide additional detail, while the applicable legal requirements remain controlling.